发明名称 METHODS FOR THE SYNTHESIS OF SPHINGOMYELINS AND DIHYDROSPHINGOMYELINS
摘要 The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.
申请公布号 US2016075634(A1) 申请公布日期 2016.03.17
申请号 US201514693520 申请日期 2015.04.22
申请人 CERENIS THERAPEUTICS HOLDING SA 发明人 Oniciu Daniela Carmen;Heckhoff Stefan;Oswald Benoit;Rebmann Peter;Peer Andreas;Gonzalez Miguel;Sauter Patrik
分类号 C07C215/24;C07C231/10;C07F9/113;C07C231/02;C07C249/02;C07C213/08;C07C233/18 主分类号 C07C215/24
代理机构 代理人
主权项 1. A method for synthesizing D-erythro-sphingosine, comprising the steps of: a) protecting the amino group of an L-serine ester having the following structure:wherein R is a C1-5 alkyl group, or a salt thereof, with a tert-butoxycarbonyl group, resulting in a Boc-protected L-serine ester; b) allowing the Boc-protected L-serine ester to react with 2,2-dimethoxypropane in the presence of benzenesulfonic acid under conditions effective to yield the corresponding C1-C5 alkyl ester of (S)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-oxazolidincarboxylic acid; c) allowing the corresponding C1-C5 alkyl ester of (S)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-oxazolidincarboxylic acid to react with dimethyl methylphosponate in the presence of n-butyllithium under conditions effective to yield (S)-3-(tert-butoxycarbonyl)-4-(2-(dimethoxy-phosphoryl)-1-oxo-ethyl)-2,2-dimethyloxazolidine; d) allowing (S)-3-(tert-butoxycarbonyl)-4-(2-(dimethoxy-phosphoryl)-1-oxo-ethyl)-2,2-dimethyloxazolidine to react with 1-tetradecanal under conditions effective to yield (S)-3-(tert-butoxycarbonyl)-4-(1-oxo-hexadec-2-enyl)-2,2-dimethyloxazolidine; e) allowing (S)-3-(tert-butoxycarbonyl)-4-(1-oxo-hexadec-2-enyl)-2,2-dimethyloxazolidine to react with sodium borohydride and cerium trichloride under conditions effective to yield (2S,3R,4E)-3-(tert-butoxycarbonyl)-4-(1-hydroxy-hexadec-2-enyl)-2,2-dimethyloxazolidine; and f) removing the tert-butoxycarbonyl (Boc) protecting group of (2S,3R,4E)-3-(tert-butoxycarbonyl)-4-(1-hydroxy-hexadec-2-enyl)-2,2-dimethyloxazolidine under conditions effective to yield D-erythro-sphingosine.
地址 Labege FR